Your account has not been permission, data will display ***. Please Upgrade to use. Close notice
Hướng dẫn sử dụng

Agimexpharm Pharmaceutical JSC (UPCoM: AGP)

34,000

1,900 (+5.92%)
03/28/2024 15:19

Open32,900

High34,000

Low32,900

Vol6,409

Market Cap.702.59

Remain Bid14,291

Remain Ask69,691

52Wk High34,000

52Wk Low21,900

52Wk Avg Vol2,684

Foreign Buy-

Frgn Owned(%)-

Dividend500

Dividend Yield0.02

Beta-0.19

EPS2,241

P/E14.31

F P/E11.42

BVPS17,164

P/B1.87

Financial ratios of latest trading date, EPS in the company's latest quarter Financial Statement
View with AGP: AFX IMP VMD TRA DHG
Trending: VND (132,426) - HPG (113,797) - NVL (110,511) - DIG (98,703) - MBB (72,317)
1 day | 5 day | 3 months | 6 months | 12 months
- Agimexpharm Pharmaceutical Joint Stock Company (Agimexpharm), formally known as An Giang Pharmaceutical Factory, was established in accordance with Decision No.52/QDD.UB on June 10th, 1981 by An Giang People's Committee. It is headquartered in 34 - 36 Ngo Gia Tu, Long Xuyen town, An Giang Province. In August 2008, Agimexpharm pharmaceutical factory under Agimexpharm received the GMP - WHO certification from Drug Ad... View more
DateCloseChangeVolume
03/28/202434,0001,900 (+5.92%)6,409
03/27/202432,900900 (+2.81%)3,227
03/26/202431,500-1,400 (-4.26%)3,100
03/25/202432,9000 (0.00%)1,668
03/22/202432,9001,100 (+3.46%)300
Volume: share, Price: Dong
Unit: Million Dong
Unit: Million Dong
06/30/2023AGP Dividend payment in cash with 5.00% for 2022 (Record date)
06/30/2023AGP Dividend payment in cash with 5.00% for 2022
06/30/2023AGP Dividend payment by share with 10.00% for 2022 (Record date)
05/06/2022AGP Dividend payment in cash with 10.00% for 2021 (Record date)
05/06/2022AGP Dividend payment in cash with 10.00% for 2021
03/18/2024Resolution of Annual Shareholders' Meeting 2024
02/24/20242024 Annual Shareholders’Meeting Documents
03/07/2024Annual report 2023
02/22/2024Audited FS 2023
01/15/2024FS Quarter 4 of 2023

Agimexpharm Pharmaceutical JSC

Name: Agimexpharm Pharmaceutical JSC

Abbreviation:AGIMEXPHARM

Address: 27 Nguyen Thai Hoc Street, My Binh Ward, Long Xuyen An Giang

Telephone: (84.296) 385 6961 - 385 6964

Fax: (84.296) 395 7301

Email:agp@agimexpharm.com

Website:https://agimexpharm.com

Exchange: UPCoM

Sector: Manufacturing

Industry: Chemical - Pharmaceutical

Listing date: 10/06/2015

Chartered capital: 206,644,530,000

Listed shares: 20,664,453

Shares outstanding: 20,664,453

Status: Operating

Tax code: 1600699279

Establishment license: 52/QĐ-UB

Issued date: 06/10/1981

Business license: 5203000020

Issued date: 06/03/2004

Main business scope:

- Trading optical, health and hospital equipment.

- Producing medicines, pharmaceutical products, pharmaceutical materials.

- Trading medicine, pharmaceutical products, nutritious food, cosmetics, vaccines.

- Trading pharmaceutical materials.

- Producing bottled water.

- Producing functional foods.

- Others under the business license.

- 1981: An Giang Pharmaceutical Factory was established;

- 1996: An Giang Pharmaceutical Company was established in the basis of merging between An Giang Medical and Pharmaceutical Materials Company and An Giang Pharmaceutical Factory;

- 2003: The company was equitized;

- 2004: Officially operated as a joint stock company, renamed as Pharmaceutical Joint Stock Company; the initial charter capital was VND 6.78 billion;

- 2007: Issued 1,522,310 shares to increase the charter capital to VND 22 billion;

- 2012: Increased the charter capital to VND 26.399 billion;

- 2013: Became a publish company;

- 2014: Increased the charter capital to VND 39.599 billion;

- June 10, 2015: Traded on the UPCOM market with the charter capital up to VND43.56 billion;

- 05 April 2017: Charter capital was raised up to VND74,049,960,000;

- 29 May 2018: Charter capital was raised up to VND96,263,830,000;

- October 10, 2019: Increased charter capital to VND128,351,770,000;

ItemsUnit
PriceVND
VolumeShares
Foreigner's, Yield%
Mkt CapbVND
Financial indicatorsmVND
EPS, BVPS, DividendVND
P/E, F P/E, P/BTimes
ROS, ROA, ROE%
1. The accounting period for the equitization year is defined as of the company's establishment date.
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.
* Vietstock tổng hợp thông tin từ các nguồn đáng tin cậy vào thời điểm công bố cho mục đích cung cấp thông tin tham khảo. Vietstock không chịu trách nhiệm đối với bất kỳ kết quả nào từ việc sử dụng các thông tin này.